Tower Research Capital (TRC)’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Other funds holding CODX
Tower Research Capital (TRC)'s CODX Position: Q3 2026 in Review
Tower Research Capital (TRC) opened a new position in Co-Diagnostics (CODX) in Q3 2026: 7,684 shares worth $8.22K. The stake represents ﹤0.01% of the portfolio and ranks #4419 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in CODX as recently as Q4 2025.
Tower Research Capital (TRC) first reported a position in CODX in Q3 2017 and has held it in 26 quarters since. The position peaked at $295K in Q3 2020. 24 funds tracked by Wall St. Rank hold CODX as of Q3 2026.
- Tower Research Capital (TRC) held 7,684 shares of Co-Diagnostics worth $8.22K as of Q3 2026.
- Co-Diagnostics was a new Tower Research Capital (TRC) position in Q3 2026.
- Co-Diagnostics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4419 holding.
- Tower Research Capital (TRC) first reported a position in Co-Diagnostics in Q3 2017 and has held it in 26 quarters since.
- Tower Research Capital (TRC)'s Co-Diagnostics position peaked at $295K in Q3 2020.
- 24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.